Post‐treatment 18F‐fludeoxyglocuse‐positron emission tomography in human papillomavirus‐associated oropharyngeal cancer
Head & Neck · 2023-08 · 45 (8) · 2000-2008
DOI: 10.1002/hed.27426 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, online erschienen am 12.06.2023. Verfasst von Zhen Yu Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Papillomavirus Infections, Oropharyngeal Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Cancer Australia, NHMRC, Royal Brisbane Women's Hospital Foundation.
Abstract (Originalsprache)
Background
Human papillomavirus association has changed the landscape of treatment for oropharyngeal squamous cell carcinoma; it remains to be seen whether current post‐treatment surveillance schedules are effective.
Objective
Evaluate whether post‐treatment surveillance of oropharyngeal cancer through FDG‐PET imaging is modified by human papillomavirus association.
Methods
A prospective cohort analysis of retrospective data was conducted for patients undergoing treatment of oropharyngeal cancer between 2016 and 2018. This study was conducted at a single large tertiary referral center in Brisbane, Australia.
Results
Two‐hundred and twenty‐four patients were recruited for the purposes of the study, 193 (86%) with HPV‐associated disease. In this cohort FDG‐PET had a sensitivity of 48.3%, specificity of 72.6%, positive predictive value of 23.7%, and negative predictive value of 88.8% in detecting disease recurrence.
Conclusions
FDG‐PET in HPV‐associated oropharyngeal cancer has significantly lower positive predictive value when compared to non‐HPV‐associated oropharyngeal cancer. Caution should be used when interpreting positive post‐treatment FDG‐PET.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
- Griffith Institute for Drug Discover and Menzies Health Institute Queensland, Griffith University, Nathan, Queensland, Australia.
- Department of Medical Imaging, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
- Queensland Institute of Medical Research, Herston, Queensland, Australia.
ORCID-Profile: Zhen Yu Liu
Förderung
- Cancer Australia
- NHMRC
- Royal Brisbane Women's Hospital Foundation
- Garnette Passe and Rodney Williams Foundation
- National Health and Medical Research Council
Zitieren
APA
Liu, Z. Y., Khoo, D., Hartel, G., Punyadeera, C., & Vasani, S. (2023). Post‐treatment 18F‐fludeoxyglocuse‐positron emission tomography in human papillomavirus‐associated oropharyngeal cancer. Head & Neck, 45(8), 2000-2008. https://doi.org/10.1002/hed.27426
Vancouver
Liu ZY, Khoo D, Hartel G, Punyadeera C, Vasani S. Post‐treatment 18F‐fludeoxyglocuse‐positron emission tomography in human papillomavirus‐associated oropharyngeal cancer. Head & Neck. 2023;45(8):2000-2008. doi:10.1002/hed.27426
BibTeX
@article{Liu2023,
author = {Liu, Zhen Yu and Khoo, Denver and Hartel, Gunter and Punyadeera, Chamindie and Vasani, Sarju},
title = {Post‐treatment 18F‐fludeoxyglocuse‐positron emission tomography in human papillomavirus‐associated oropharyngeal cancer},
journal = {Head & Neck},
year = {2023},
volume = {45},
number = {8},
pages = {2000--2008},
doi = {10.1002/hed.27426}
}
EUVIMED